RadNet
Operates outpatient imaging centers and sells DeepHealth radiology software and clinical AI.
Something off on this page? Send us feedback.
Profile
Operates fixed-site outpatient imaging centers that earn fees for MRI, CT, PET, mammography and other scans, while DeepHealth sells radiology software, remote-scanning tools and clinical AI. Revenue remains dominated by the U.S. center network and depends on physician referrals and third-party reimbursement.
Runs the Imaging Centers segment, a U.S. network of 442 fixed-site outpatient centers offering MRI, CT, PET, mammography, ultrasound, X-ray, nuclear medicine and fluoroscopy. Builds density in regional markets through acquisitions, new sites and health-system joint ventures; multimodality locations broaden referral coverage and improve equipment use. Scan volume and service mix drive revenue, with advanced imaging generally carrying higher margins than routine exams.
Sells Digital Health products under DeepHealth, including RIS/PACS, DeepHealth OS, clinical AI, reporting and remote-scanning tools, to its own network and outside hospitals, health systems and imaging providers worldwide. The segment expanded into routine and acute-care imaging through Gleamer. Operations depend on physician referrals, commercial and government reimbursement, qualified radiologists and technologists, and continuing investment in imaging equipment and regulated clinical software.
Company facts
Key statistics
Year to date +5.2% · Average volume (30d) 687.2K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| May 20, 2026 | Barclays | Reiterate | Overweight | $79 | $65 | |
| Mar 3, 2026 | Jefferies | Target | $100 | $91 | ||
| Jan 9, 2026 | UBS | Target | $92 | |||
| Jan 8, 2026 | KeyBanc | Target | $92 | |||
| Dec 17, 2025 | Truist Financial | Target | $81 | $90 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 9, 2026Q2 FY26 | $0.20 | $0.29 | +44.0% | $610.9M | $622.7M | +1.9% | +6.76% |
| May 11, 2026Q1 FY26 | −$0.14 | −$0.28 | −100.0% | $557.9M | $575.6M | +3.2% | +0.18% |
| Mar 2, 2026Q4 FY25 | $0.19 | $0.23 | +21.1% | $516.7M | $547.7M | +6.0% | −3.51% |
| Nov 9, 2025Q3 FY25 | $0.22 | $0.20 | −10.3% | $494.5M | $522.9M | +5.7% | +3.24% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $471.4M | $498.2M | $522.9M | $547.7M | $575.6M | $622.7M | |
| Gross profit | $17.9M | $69.1M | $72.5M | $75.9M | −$16.4M | $88.1M | |
| Operating income | −$24.1M | $30.9M | $32.7M | $35.1M | −$16.4M | $39.5M | |
| Net income | −$37.9M | $14.5M | $5.4M | −$597.0K | −$33.5M | $7.5M | |
| Diluted EPS | −$0.51 | $0.19 | $0.07 | −$0.01 | −$0.43 | $0.10 | |
| Gross margin | 3.8% | 13.9% | 13.9% | 13.9% | -2.8% | 14.1% | |
| Operating margin | -5.1% | 6.2% | 6.3% | 6.4% | -2.8% | 6.3% |
Fiscal years (4-quarter sums)FY21 $1.32B · FY22 $1.43B · FY23 $1.62B · FY24 $1.83B · FY25 $2.04B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $726.3M · Total debt $2.18B · Total assets $4.23B · Shareholders' equity $1.10B
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 78.63M · Float 70.36M · 89.5% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 10.96M | 13.94% | 13F | Aug 7, 2026 |
| RTW Investments, LP | 4.85M | 6.16% | 13F | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 4.50M | 5.72% | 13F | Aug 14, 2026 |
| T. Rowe Price Associates, Inc. | 4.15M | 5.40% | 13G | May 15, 2026 |
| Vanguard Portfolio Management LLC | 4.07M | 5.17% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 18, 2026 | David L. Swartz | director | −2,699 | $53.89 |
| Jun 16, 2026 | Cornelis Wesdorp | officer: Pres & CEO, Digital Health | −4,750 | $58.11 |
| Jun 15, 2026 | Stephen M. Forthuber | officer: Pres & CEO-Eastern Operations | −44,067 | $58.16 |
| Mar 19, 2026 | Alma Gregory Sorensen | director, officer: Chief Strategy Officer | −15,000 | $62.20 |
| Mar 18, 2026 | Alma Gregory Sorensen | director, officer: Chief Strategy Officer | −15,000 | $62.15 |
Peers
- GE HealthCare
Imaging hardware giant with 115 FDA-cleared AI algorithms across modalities
- HCA Healthcare
Largest US hospital; hospital-owned outpatient imaging competes for volume
- Philips (ADR)
Dutch health-tech giant; IntelliSpace AI informatics competes with DeepHealth OS
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| RadNet | $74.61 | −0.05% | $5.87B | — | 110.4 | 2.6 | +25.0% |
| GE HealthCare | $71.73 | −0.01% | $32.40B | 20.8 | 13.8 | 1.6 | +5.8% |
| HCA Healthcare | $417.82 | −0.00% | $90.46B | 14.0 | 13.6 | 1.2 | +8.7% |
| Philips (ADR) | $26.72 | +0.06% | $26.12B | 19.9 | 13.7 | 1.3 | −2.9% |
| Median | 19.9 | 13.7 | 1.3 | +5.8% |